Education:
University of Iowa
Biomedical Engineering major
B.S., 2021
MSTP Student Governance:
- JEDI Committee, 2024-2025
- WISM, 2024-2025
Thesis advisor: Matthew Johnson, Ph.D.
Publications
For work prior to the UMN MSTP:
Gates TJ, Zbidat S, Deniz K, Padmanabhan S, Ladner K, Sarkari A, Zhao X, Davidi S, Blatt R, Cahal S, Gabay M, Sellevoll M, Tzchori I, Porat Y, Haber A, Giladi M, Subramanian S, Lou E. Protocol for applying Tumor Treating Fields in mouse models of cancer using the inovivo system. STAR Protoc. 2025 Mar 21;6(1):103535. doi: 10.1016/j.xpro.2024.103535. PMCID: PMC11780090
Padmanabhan S, Deniz K, Sarkari A, Lou E. Tunneling Nanotubes: Implications for Chemoresistance. Results Probl Cell Differ. 2024;73:353-373. doi: 10.1007/978-3-031-62036-2_15. Review.
Sarkari A, Korenfeld S, Deniz K, Ladner K, Wong P, Padmanabhan S, Vogel RI, Sherer LA, Courtemanche N, Steer C, Wainer-Katsir K, Lou E. Treatment with tumor-treating fields (TTFields) suppresses intercellular tunneling nanotube formation in vitro and upregulates immuno-oncologic biomarkers in vivo in malignant mesothelioma.Elife. 2023 Nov 13;12:e85383. PMCID: PMC10642963
Ceran Y, Ergüder H, Ladner K, Korenfeld S, Deniz K, Padmanabhan S, Wong P, Baday M, Pengo T, Lou E, Patel CB. TNTdetect.AI: A Deep Learning Model for Automated Detection and Counting of Tunneling Nanotubes in Microscopy Images. Cancers (Basel). 2022 Oct 10;14(19):4958. PMCID: PMC9562025
Moser JC, Salvador E, Deniz K, Swanson K, Tuszynski J, Carlson KW, Karanam NK, Patel CB, Story M, Lou E, Hagemann C. The Mechanisms of Action of Tumor Treating Fields. Cancer Res. 2022 Oct 17;82(20):3650-3658. PMCID: PMC9574373
Pandey M, Xiu J, Mittal S, Zeng J, Saul M, Kesari S, Azadi A, Newton H, Deniz K, Ladner K, Sumrall A, Korn WM, Lou E. Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields. Neurooncol Adv. 2022 Jun 21;4(1):vdac096.
